In a mouse model of allergic asthma, Benetti et al. [42] demonstrated that treatment with NaHS is able to prevent pulmonary allergic inflammation by increasing the expression of SOD, GR, and GPx enzymes. The gene discussed is NR3C1; the disease is allergic asthma.